Form 4: NeuroOne Medical Technologies Executive Disposes of Shares to Cover Tax Obligations

Mark Christianson, Business Development Director at NeuroOne Medical Technologies, disposed of 253 shares of common stock on March 31, 2025, to cover tax obligations.

Summary

• On March 31, 2025, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, disposed of 253 shares of common stock.
• The transaction was executed to cover tax obligations arising from the vesting of restricted stock units.
• The shares were disposed of at a price of $0.8502 per share.
• Following the transaction, Christianson directly owns 291,491 shares of NeuroOne Medical Technologies Corp.

Sentiment

Score: 5

Explanation: This is a neutral transaction related to tax obligations. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This transaction is related to tax obligations, which is a common reason for share disposals.

Stakeholder Impact

• The disposal of shares by an insider could have a minor impact on shareholder sentiment, but is unlikely to be significant given the small number of shares involved and the reason for the disposal.

Key Dates

Keywords

Form 4, NeuroOne Medical Technologies, NMTC, Mark Christianson, Business Development Director, Share Disposal, Tax Obligations, Insider Trading